Samsung Electronics Co., Ltd.

1st Biotherapeutics, Inc.

Hyundai Motor Company

Kia Corporation

Samsung Electro-mechanics Co., Ltd.

The Green Cross Corporation

Jae Eun Kim

Jinhwa Lee

Suyeon Jo

Misoon Kim

A Yeong Park

Keonseung Lim

Walter Jun

Hyun Seok Kim

Sung-wook Kim

Chang Hyun Kim

Seung Jae Lee

Ji-Hoon Kim

Hyun Jung Kim

Minwoo Lee

Sung Woo Han

Min Woo Lee

Sung-Wook Kim

Hyo Rang Kang

Kisoo Park

Jungwoo Lee

Suk Ho Lee

Hee Jeong Seo

Min Ju Kim

Tae Won Kim

Sung Soo Han

Kwang-Seop Song

Eun-Jung Park

Soongyu Choi

Hyo A Kang

Bok Soon Kwon

Mi-Soon Kim

Jong Duck Kim

Myung Eun Jung

Younggyu Kong

Jung Im Han

Joon Seon Jeong

So Ok Park

Hyo Sik Kang

Seung Mook Lim

Bo Kyung Jung

Yeonguk Jeon

Gadhe Changdev Gorakshnath

Hwajung Nam

Yejin Hwang

Seung-Woo Lim

Jaehwan Lim

Inyoung Yang

Yoo Seong Yang

Man-Young Cha

Ickhwan Son

Kinam Lee

You Hwan Son

Hyunku Kang

Jun Sung Lee

Jae Hwan Lim

Gwibin Lee

Hyeongjun Kim

Wanjun Li

Mingzhu Fan

Daehun You

So-Geum Kim

Ho Jung Yang

Chan Hyeok Lee

Gyooseung Jung

Heekyoung Yang

Hyonam Kim

Joo Wook Lee

Ki Soo Kim

Dae Hun You

A power supply of a motor for a vehicle includes: a terminal block mounted to a motor housing to prevent disconnection of a terminal connection portion configured to supply power to a stator coil of the motor; a terminal plate electrically connected to the terminal block; a bus bar provided on the terminal plate; a stator coil having a conductive connection terminal electrically connected to the bus bar; and an elastic member mounted to the bus bar and the conductive connection terminal to reduce vibration applied to the bus bar and the conductive connection terminal.

Power supply of a vehicle motor having an elastic member with a coupling portion

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent inflammatory and autoimmune diseases, especially neuroinflammation diseases using the compound.

Compounds for prevention or treatment of neurodegenerative disorders

A storage device includes a nonvolatile memory device and a storage controller. The storage controller accesses the nonvolatile memory device based on a request of an external host device. The storage controller sends a signal to the external host device, based a throughput of accessing the nonvolatile memory device being within a specific range.

Storage device, operating method of storage device, and electronic device

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds.

Substituted indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors

A storage device includes a nonvolatile memory device and a controller that accesses the nonvolatile memory device based on a request of an external host device, receives a first clock signal from the external host device, generates a second clock signal through frequency multiplication of the first clock signal, and communicates with the external host device based on the second clock signal. The controller requests the external host device to adjust a multiplication ratio for the frequency multiplication of the first clock signal.

Storage device and operating method of storage device

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent neurodegenerative diseases using the compound.

Imidazopyridinyl compounds and use thereof for treatment of neurodegenerative disorders

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method for treating or preventing an inflammatory and autoimmune diseases, especially neuroinflammation diseases using the compound.

2-amino-3-carbonyl imidazopyridine and pyrazolopyridine compounds

A bobbin structure is inserted into a slot defined in a stator core. The bobbin structure includes a body configured to contact an inner wall of the slot and at least one partition provided inside the body to insulate at least some coils, inserted into the slot so as to be arranged in a plurality of layers, from each other. The body and the at least one partition are formed integrally with each other.

Bobbin structure for partioning coil layers

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salts thereof, a composition comprising the compound, methods of using the compound for the treatment of various disorders associated with HPK1, and methods of preparing these compounds. 

Indazoles as hematopoietic progenitor kinase 1 (HPK1) inhibitors and methods using same

A redundant array of independent disks (RAID) storage device including; a memory device including first memory devices configured to store at least one of data chunks and corresponding parity (data chunks/parity) and a second memory device configured to serve as a spare memory region, and a RAID controller including a RAID internal memory configured to store a count table and configured to control performing of a rebuild operation in response to a command received from a host, wherein upon identification of a failed first memory device, the RAID controller accesses used regions of non-failed first memory devices based on the count table and rebuilds data of the failed first memory device using the second memory device.

RAID storage device, host, and RAID system

The present disclosure provides a compound of Formula (I) or pharmaceutically acceptable salt, stereoisomers thereof, a pharmaceutical composition comprising the compound, and a method to treat or prevent neurodegenerative diseases using the compound. 

The present disclosure provides a compound of general Formula (I) having c-abl kinase inhibitory activity or pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound, and a method useful to treat or prevent neurodegenerative diseases using the compound. 

Benzothiazol compounds and methods using the same for treating neurodegenerative disorders

A capacitive deionization electrode may include a conductive material and a polymer on a surface of the conductive material. The polymer may have at least one functional group in a single polymer chain.

Capacitive deionization electrodes, capacitive deionization apparatuses including the same, and production methods thereof

A draw solute for forward osmosis may include a temperature-sensitive oligomer compound including a structural unit including a temperature-sensitive moiety. The temperature-sensitive oligomer compound may further include a hydrophilic functional group at the terminal end of the main chain.

Draw solute for forward osmosis, forward osmosis water treatment device, and forward osmosis method for water treatment

A thermosensitive copolymer may include a first repeating unit having a temperature-sensitive oligomer and a second repeating unit having an ionic moiety and a counter ion to the ionic moiety. The temperature-sensitive oligomer may be an oligomer including a repeating unit derived from a unsaturated monomer with a moiety represented by Chemical Formula 1 or Chemical Formula 2, or an oligomer including a repeating unit derived from a heterocyclic compound having C, N, O, and a C&#x2550;N bond in its ring.*&#x2014;C(&#x2550;O)N(R)(R)&#x2003;&#x2003;[Chemical Formula 1]Rand Rmay each independently be hydrogen or a linear or branched C1 to C6 alkyl group, a C3 to C7 cycloalkyl group, or a C6 to C10 aryl group, Rand Rmay not both be hydrogen, and Rand Rmay be combined to form a nitrogen containing heterocycle. Rmay be a C2 to C5 alkylene group.

Thermosensitive copolymers, forward osmosis water treatment devices including the same, and methods of producing and using the same

Growing community of inventors

Seoul, South Korea

Jae Eun Kim